Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
Ludwigshafen, Germany
Augenklinik, Ludwigshafen am Rhein, Rheinland-Pfalz
About Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
During the past decade, Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
A Study of the Efficacy, Safety, and Pharmacokinetics of A 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
2021-03-02
2023-07-13
Active, not recruiting
729
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
According to Clinical.Site data, the most researched conditions in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik" are
"Geographic Atrophy" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials), "Central Retinal Vein Occlusion" (1 trials) and "Hemiretinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
Most popular intervention types in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik" are "Drug" (5 trials), "Procedure" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aflibercept" (2 trials), "Faricimab" (2 trials), "Lampalizumab" (2 trials), "Sham Procedure" (2 trials) and "Port Delivery System with Ranibizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
The vast majority of trials in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik" are
5 trials for "All" genders.
Clinical Trials Status at Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik
Currently, there are NaN active trials in "Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum der Stadt Ludwigshafen am Rhein gGmbH; Augenklinik, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".